| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/31/2008 | CA2658518A1 Cyclosporin compositions |
| 01/31/2008 | CA2657817A1 Caspofungin formulations |
| 01/31/2008 | CA2657563A1 Post-translationally modified neurotrophins |
| 01/31/2008 | CA2657164A1 Compositions and methods for treating or preventing ophthalmic light toxicity |
| 01/31/2008 | CA2650520A1 Treatment of ras-expressing tumors |
| 01/30/2008 | EP1882698A1 Design of interferon-inducible protein-10 (IP10 or CXCL10) chemokine analogs for the treatment of human diseases |
| 01/30/2008 | EP1882697A1 Post-translationally modified neurotrophins |
| 01/30/2008 | EP1882696A2 PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
| 01/30/2008 | EP1882033A2 Materials and methods for regulating blood flow |
| 01/30/2008 | EP1881962A2 Thiosuccinic acid derivatives and the use thereof |
| 01/30/2008 | EP1881842A1 Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries |
| 01/30/2008 | EP1881841A1 Compositions comprising tripeptides inhibiting ace |
| 01/30/2008 | EP1881840A1 N-acetylcysteine amide (nac amide) for treatment of oxidative stress associated with infertility |
| 01/30/2008 | EP1881835A1 Triazine compounds and compositions thereof for the treatment of cancers |
| 01/30/2008 | EP1881828A1 Treatment of hcv with subtherapeutic doses of ribavirin |
| 01/30/2008 | EP1399471B1 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
| 01/30/2008 | EP1163254B1 Trpm-2 antisense therapy |
| 01/30/2008 | EP0972063B1 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 01/30/2008 | EP0941125B1 Methods for regulating angiogenesis |
| 01/30/2008 | EP0737249B1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor |
| 01/30/2008 | CN101115846A Mammalian genes involved in infection |
| 01/30/2008 | CN101115839A Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein |
| 01/30/2008 | CN101115770A Pyy agonists and uses thereof |
| 01/30/2008 | CN101115769A Interferon-alpha polypeptides and conjugates |
| 01/30/2008 | CN101115767A vWFA and/or ANTúIG domain containing proteins |
| 01/30/2008 | CN101115505A Method and composition for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite |
| 01/30/2008 | CN101115498A Hiv-1 gp41 fusion peptides for immunomodulation |
| 01/30/2008 | CN101115497A Food for preventing life style-related diseases |
| 01/30/2008 | CN101115496A Methods for improving the structure and function of arterioles |
| 01/30/2008 | CN101115495A Method to enhance the bone formation activity of bmp by RUNX2 acetylation |
| 01/30/2008 | CN101115494A Method of modulating vascularization |
| 01/30/2008 | CN101115468A Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion |
| 01/30/2008 | CN101115388A Cell permeabilization and stabilization reagent and method of use |
| 01/30/2008 | CN101113982A Method for screen selecting polypeptides excitomotor of glucagon-like peptide-1 receptor in vitro |
| 01/30/2008 | CN101113450A Neurotrophic factor |
| 01/30/2008 | CN101113449A Neurotrophic factor |
| 01/30/2008 | CN101113448A Agkistrodon halys ussuriensis disintegrin site-directed mutants cDNA clone, expression and protein preparation method and application thereof |
| 01/30/2008 | CN101113179A Human antibody sample molecule TEM8-Fc based on tumour endocytosis sign 8 and its application in tumour treatment |
| 01/30/2008 | CN101113173A Synthetic antimicrobial polypeptides |
| 01/30/2008 | CN101113172A Anti-opium peptide and antagonistic peptide and its application |
| 01/30/2008 | CN101113171A Peptide for increasing animal food ingestion |
| 01/30/2008 | CN101113170A Preparation of new gene cell cycle related tumour high-expression gene monoclonal antibody and its application |
| 01/30/2008 | CN101113169A Use of sorting protein SNX10 for suppressing growth of tumour cell |
| 01/30/2008 | CN101113163A Hla-a24-restricted cancer antigen peptides |
| 01/30/2008 | CN101113162A Method for extracting centipede acidic protein and application of centipede acidic protein extracted by the method in preparation of medicine for treating heart disease |
| 01/30/2008 | CN101112615A Antineoplastic health food product formulation |
| 01/30/2008 | CN101112614A Glair NRBP having important functions in regulating and controlling in immunoregulation |
| 01/30/2008 | CN101112365A Method for preparing Nabothí»s cyst containing manifold cell growth factors and use thereof |
| 01/30/2008 | CN101112358A Staphylokinase intramuscular injection and method for preparing the same |
| 01/30/2008 | CN100365120C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2008 | CN100365119C Polypeptide of anti HIV virus and its coding gene and application |
| 01/30/2008 | CN100365117C Pegylated and diglycosylated erythropoietin |
| 01/30/2008 | CN100365022C Fusion toxin protein and uses thereof |
| 01/30/2008 | CN100365021C Nucleic protein 'Shoca'-a component of wnt signal transmission channel |
| 01/30/2008 | CN100365020C Protein from snake venom for preventing and treating pyemia |
| 01/30/2008 | CN100365018C Antibiotic peptides and their prepn process and application |
| 01/30/2008 | CN100365017C Antigenic polypeptide of chlamydia pneumoniae |
| 01/30/2008 | CN100365016C Series peptide for promoting proliferation of bone marrow karyota and bone marrow substrate cell and its application |
| 01/30/2008 | CN100365015C 12-mer peptide, compound containing the same, its preparation method and application in cancer treatment drug |
| 01/30/2008 | CN100365014C Tumor targeting agents and uses thereof |
| 01/30/2008 | CN100364611C Peptide immunotherapeutic agent |
| 01/30/2008 | CN100364610C Method for raising utilizing degree to oral organism-absorbing of lumbrukinase |
| 01/30/2008 | CN100364609C Prekallikrein depleted plasma derived albumin fraction |
| 01/30/2008 | CN100364608C Slow release parathyroid hormone microballoon |
| 01/30/2008 | CN100364607C Use of compound PS-341 in preparing medicine for treating chronic granulocytic leukemia |
| 01/30/2008 | CN100364606C Peptide compositions and formulations and use of same |
| 01/30/2008 | CN100364517C Water-soluble medicine degradable polymer microcapsule injecta and preparing method |
| 01/30/2008 | CN100364499C Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 01/29/2008 | US7324846 Method of enchancing electrontransport polypeptide flux by amino acid substitution with histidine |
| 01/29/2008 | US7323616 Genetically altered mice deficient in functional caspase-9 |
| 01/29/2008 | US7323552 Genetic engineering; diagnosis of antiinflammatory agents |
| 01/29/2008 | US7323550 Anti-PRO4318 antibodies |
| 01/29/2008 | US7323549 IL-7 fusion proteins |
| 01/29/2008 | US7323548 Antibodies or active fragments specific for MORT-1 (Mediator of Receptor Toxicity) protein having amino acid sequence 2; tumors, hiv |
| 01/29/2008 | US7323546 Apoptosis-inducing polypeptides |
| 01/29/2008 | US7323545 PRO1885 polypeptides |
| 01/29/2008 | US7323544 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 01/29/2008 | US7323543 Insulin, insulin-related peptide, and sensitizer; side effect reduction |
| 01/29/2008 | US7323542 Bioactive amino acid sequences conjugated with biocompatible, biodegradable delivery system for use in treatment and prevention of bone disorders: prosthetics |
| 01/29/2008 | US7323541 Polypeptide DNA thereof and use of the same |
| 01/29/2008 | US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 01/29/2008 | US7323489 As prodrug of enalaprilat, which is a medicine useful for preventing or treating circulatory diseases such as hypertension, cardiac diseases, nephritis, and apoplexy, patches; 1-[N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline 2-hydroxyethyl ester |
| 01/29/2008 | US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis |
| 01/29/2008 | US7323452 Method for the accelerated in vivo removal of ethanol |
| 01/29/2008 | US7323448 Antibacterial agents |
| 01/29/2008 | US7323447 Hepatitis C virus inhibitors |
| 01/29/2008 | US7323446 Growth factor homolog ZVEGF4 |
| 01/29/2008 | US7323445 Methods and compositions for healing and repair of articular cartilage |
| 01/29/2008 | US7323444 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
| 01/29/2008 | US7323443 Lactoferrin in the reduction of pain |
| 01/29/2008 | US7323442 Due to bacteria infections; administering lactoferrin |
| 01/29/2008 | US7323441 Oral administration in a daily dosage of 150 to 750 mg per day in a form of tablets, capsules, granules, powder, or syrups |
| 01/29/2008 | US7323440 De-immunized MOG (poly)peptide constructs |
| 01/29/2008 | US7323439 Methods and compositions for modulating angiogenesis |
| 01/29/2008 | US7323340 Compositions and methods for regulating bacterial pathogenesis |
| 01/29/2008 | US7323334 Using prokineticin receptor as diagnostic screening tool to identify modulators of nervous system development; treating neurodegenerative disorders |
| 01/29/2008 | US7323181 Compositions and methods for WT1 specific immunotherapy |
| 01/29/2008 | US7323179 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
| 01/29/2008 | US7323175 Immunogenicity of glucan binding protein |
| 01/29/2008 | US7323174 Modulation of immune response and methods based thereon |